Frontiers in oncology.

Scope. Breast Cancer is a specialty section of Oncology dedicated to advancing scientific and clinical knowledge of breast cancers. This section seeks to publish articles addressing novel findings, controversies, and innovative hypotheses in the areas of prevention, diagnosis, and treatment of early breast lesions and breast malignancies. Treatment effect on contrast-enhanced tumor (CET) was evaluated according to the response assessment in neuro-oncology (RANO) criteria for clinical trials . In addition, an automated software-based method developed in house was used to objectively calculate the CET volume (see below and Supplementary Appendix ). In Vitro Peptide Re-Stimulation (IVS) of the Murine Splenocytes. Fresh splenocytes isolated from vaccinated animals were stimulated with either HAGE 30-mer long peptides, WT1 15-mer long peptides or both, at a concentration of 1μg/mL in the presence of β-mercaptoethanol and 50U/mL mIL-2 for 7 days at 37°C in a 5% (v/v) CO 2 incubator.Sep 8, 2022 ... Welcome to this conference regarding cancer research and therapy organized by the Department of Oncology-Pathology.

timothy james kinsella. Department of Radiation Oncology, Warren Alpert Medical School, Brown University. Providence, United States. Specialty Chief Editor. Radiation Oncology.

Frontiers in Oncology is a broad-scope, multidisciplinary journal covering all areas of cancer research to advance our knowledge of cancer epidemiology to improve diagnosis, therapeutics and ...

Submissions that are surgical in nature are not in scope for this section and should be submitted to the Surgical Oncology Section of Frontiers in Oncology. Case Reports should include correlative data and expand the current knowledge on the pathophysiological and clinical manifestations of cancer while discussing the cellular and …New Therapeutic Approaches for Pediatric Glioma: Pre-Clinical and Clinical Studies. Mark Atlas. Derek Hanson. Oren Becher. 395 views. This section aims to create an open access, rapid, transparent and interactive exchange of findings for the neuro-oncology and neurosurgical oncology communities.Jürgen Schlegel. Ekkehard Hewer. Bianca Pollo. Theoni Maragkou. Frontiers in Oncology. doi 10.3389/fonc.2024.1389608. This section aims to create an open access, rapid, transparent and interactive exchange of findings for the neuro-oncology and neurosurgical oncology communities.Further, Artificial Intelligence and Machine Learning (ML) techniques are also being interlaced with omics strategies to shed light on these molecular mechanisms and provide insight into the genetic and molecular abnormalities that are at play in oral cancer.ML strategies enhance the opportunities to discover novel predictive models for …

Hydrogen fuel stations map

Strauss GM, Herndon JE 2nd, Maddaus MA, Johnstone DW, Johnson EA, Harpole DH, et al. Adjuvant paclitaxel plus carboplatin compared with observation in stage ib non-small-cell lung cancer: calgb 9633 with the cancer and leukemia group B, radiation therapy oncology group, and north central cancer treatment group study groups.

Visitors may also download and forward articles subject to the citation requirements and subject to any fees POR's publisher, Frontiers, may charge for ...Getting started. The submitting and corresponding author (s) must register and log in with Frontiers to be able to follow the review process. Ensure that your manuscript fits the scope of the journal/section/Research Topic in which it will be submitted and that you have chosen the correct article type. Submission of the wrong article type or to ...2.1 Characterization of Resistance in Cancer. Drug resistance in cancer is an intimate occurrence that results when cancer becomes tolerant of pharmaceutical treatment ().An extensive range of factors contributes to the development of resistance against anticancer drugs, including genetic mutations, altered epigenetics, enhanced drug efflux, …4 days ago · See all (158) Learn more about Research Topics. Part of a multidisciplinary journal, this section explores all aspects of hematological malignancies, including acute and chronic leukemia, lymphoma and plasma and hematopoietic stem cell disorders. Added 14 August 2012 • Updated 12 January 2024. A peer-reviewed, open access journal in cancer research, clinical oncology, cancer genetics, molecular targets & surgical oncology.Radiotherapy for Esophageal Cancer: Molecular Mechanism and Novel Targets to Improve Radiosensitivity. Xiaodong Li. Yanqing Liu. Adam Yongxin Ye. Xiao Zheng. 7,350 views. 6 articles. Part of a multidisciplinary journal, this section focuses on the investigation of tumorigenesis, prevention, early detection and treatment of gastric and ...Frontiers has a community retraction protocol in place to retract papers where serious concerns have been raised and validated by the community that warrant retraction, including ethical concerns, honest errors or scientific misconduct. Explores research into the molecular and cellular mechanisms of carcinogenesis and cancer progression.

Frontiers in Cardiovascular Medicine: Rising Stars 2023. Kazufumi Nakamura. Ricardo Sanz-Ruiz. David Marti. Manuel M Mazo. Diana S Nascimento. Elisa Avolio. Olaf Bergmann. Rajesh Katare.Breast cancer: miRNAs monitoring chemoresistance and systemic therapy. Shivam Singh 1 Heena Saini 2 Ashok Sharma 3 Subhash Gupta 1 V. G. Huddar 4 Richa Tripathi 2*. 1 Department of Radiation Oncology, Dr. B. R. Ambedkar Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, India.Genetics, genomics and RNA-based biomarker development. Whole genome studies and focused studies of individual genes contributing to cancer molecular pathways. New rationales for bringing molecular genetic findings to the clinical oncology space. Submissions not in scope for this specialty include: Those consisting solely of …Frontier Airlines is a popular low-cost carrier that offers budget-friendly travel options for those looking to explore new destinations without breaking the bank. With a focus on ...Marry M. van den Heuvel-Eibrink. Archie Bleyer. Frontiers in Oncology. doi 10.3389/fonc.2024.1336714. 838 views. Part of a multidisciplinary journal, this section publishes quality basic science, translational studies, and clinical trials in the field of pediatric oncology.

Frontiers in Oncology has an h-index of 121.It means 121 articles of this journal have more than 121 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each …

Mar 18, 2022 ... Nutrition Frontiers - Winter 2022 ... This issue of Nutrition Frontiers showcases gut permeability with calcium and/or vitamin D3, microRNAs role ...Cerdanyola del Vallès, Spain. Associate Editor. Cancer Imaging and Image-directed Interventions. Part of a multidisciplinary journal, this section explores the results from clinical and research imaging studies applied to cancer discovery, diagnosis, and treatment.As an oncology nurse, staying up-to-date with the latest advancements and best practices in your field is essential. Continuing education not only helps you enhance your knowledge ...priya ranjit bhosale. University of Texas MD Anderson Cancer Center. Houston, United States. Associate Editor. Gynecological Oncology.Our vision for the program is Comprehensive Cancer Care and Optimized Cancer Survival by 2025. We hope to achieve the vision of our country, that is, the ...Optimizing the first-line treatment for metastatic colorectal cancer. The prognosis of metastatic CRC (mCRC) patients has significantly improved in the past 20 years thanks to the introduction of novel therapeutic approaches, including surgery of liver, lung and peritoneal metastases, and of more effective anticancer drugs and combinatory ...Safeguarding peer review to ensure quality at scale. Making scientific research open has never been more important. But for research to be trusted, it must be of the highest quality. Facing an industry-wide rise in fraudulent science, Frontiers has increased its focus on safeguarding quality. PRESS RELEASE.The Impact Factor for Frontiers in Oncology is based on 2,358 citations in 2017 to 296 articles published in 2015 and 2016, and for CiteScore is based on 4,138 citations in 2017 to 930 articles published in 2014, 2015 and 2016. A total of 222 journals are listed in the Oncology category in the 2017 JCR edition, of which 37 are Open Access.Frontier Communications is one of the largest telecommunications companies in the United States, providing high-speed internet, phone, and TV services to millions of customers acro...Targeting Tumor Microenvironment and Metabolic Reprogramming in Triple-negative Breast Cancer. Weipeng Zhao. Lili Yang. Shengyu Yang. 11,564 views. 5 articles. This section explores basic science, translational and clinical aspects of Cancer Metabolism, with a particular emphasis on energy metabolism and metabolic reprogramming in cancer cells.

Map of midland tx

The Urologic Oncology section of Frontiers in Urology publishes high-quality fundamental clinical and translational research, as well as, in-depth reviews across the field of urologic oncology. This section covers the areas including, but not limited to: - Renal cell carcinoma and other renal pathology - Prostate cancer - Bladder cancer

Browse the latest research topics in oncology, covering various aspects of cancer biology, diagnosis, treatment and prevention. Find articles on mitochondrial dysregulation, skull-base tumours, radiation therapy, immunotherapy, nanomaterials, and more.Our goal is to encourage interdisciplinary communication and collaborative research among basic scientists, epidemiologists, clinicians, and public health … This section on Pharmacology of Anti-Cancer Drugs is devoted to the publication of high quality research concerning all aspects of cancer and benign neoplasm drug treatment. The scope of the specialty section encompasses studies related to drugs targeting tumor cells, but also the various components of the tumor microenvironment, including non ... Frontiers in Oncology. Published by Frontiers. Online ISSN: 2234-943X. Disciplines: Geriatrics and Gerontology. Journal website Author guidelines. Top read articles. 211 reads in the past... Frontiers Media S.A., Switzerland Manuscripts accepted in English LCC subjects Look up the Library of Congress Classification Outline Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens Keywords Minimally Invasive Therapies and Molecular Mechanisms Related to Recurrence in Hepatobiliary and Gastric Cancers. Part of a multidisciplinary journal, this section focuses on the investigation of tumorigenesis, prevention, early detection and treatment of hepato pancreatic biliary neoplasia.Jan 9, 2024 · Perspective: rethinking therapeutic strategies in oncology. Immuno-oncology has revolutionized cancer care, drug development, the design of clinical trials, standard treatment paradigms, and the evaluation of response to therapy. These are all areas, however, that have not fully incorporated principles of tumor immunology. This section provides broad mechanistic and translational insights into all aspects of cancer and its interaction with components of the tumor-microenvironment.Frontiers has a community retraction protocol in place to retract papers where serious concerns have been raised and validated by the community that warrant retraction, including ethical concerns, honest errors or scientific misconduct. Explores research into the molecular and cellular mechanisms of carcinogenesis and cancer progression.

Mar 18, 2022 ... Nutrition Frontiers - Winter 2022 ... This issue of Nutrition Frontiers showcases gut permeability with calcium and/or vitamin D3, microRNAs role ...Perspective: rethinking therapeutic strategies in oncology. Immuno-oncology has revolutionized cancer care, drug development, the design of clinical trials, standard treatment paradigms, and the evaluation of response to therapy. These are all areas, however, that have not fully incorporated principles of tumor immunology.Editorial: Novel targets for ovarian cancer stem cells. Although ovarian cancer (OC) has been considered as a chemo-sensitive tumor type, the majority of patients develop chemoresistance, which drives tumor relapse within two years. Cumulative evidence supports that the presence of cancer stem cells (CSCs), in tumor residuals are …Instagram:https://instagram. general availability Breast cancer: miRNAs monitoring chemoresistance and systemic therapy. Shivam Singh 1 Heena Saini 2 Ashok Sharma 3 Subhash Gupta 1 V. G. Huddar 4 Richa Tripathi 2*. 1 Department of Radiation Oncology, Dr. B. R. Ambedkar Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, India. rvc v2 How we publish. Frontiers' approach to publishing is driven by the principle of placing publishing back into the hands of researchers, enabled by scalable technology. This means we distribute editorial responsibility to the editorial board who take acceptance or rejection decisions and have the independence to shape the direction of research. five nights at freddy's 1 free This section provides broad mechanistic and translational insights into all aspects of cancer and its interaction with components of the tumor-microenvironment.Survival of 48866 cancer patients: results from Nantong area, China. Objective: This study aimed to provide a realistic observation of survival by major site for 48,866 cancer patients treated at a tertiary cancer hospital in a rural area of China. Methods: Patients with cancer registered between 2007 and 2017 in the Nantong rural … orchestra of lights hub Background. Immune checkpoint inhibitors (ICIs) are a class of antitumor drug that activate lymphocytes, which then attack tumor cells by relieving immune checkpoint-mediated immune-suppression (1, 2).In 2015, two types of ICIs (nivolumab and pembrolizumab) were approved by the U.S. Food and Drug Administration for the … wlwt tv 5 cincinnati Frontiers in Oncology is a broad-scope, multidisciplinary journal covering all areas of cancer research to advance our knowledge of cancer epidemiology to improve diagnosis, therapeutics and ... 本文介绍了瑞士期刊《Frontiers in Oncology》的发展历程、影响因子、发文量、审稿速度、版面费等情况，以及该刊的优缺点和投稿建议。该刊是一本涵盖肿瘤癌症各个领域的开 … essentia my health my health Tumor-initiating cells (TICs) share many functional characteristics with normal stem cells and are important drivers of tumor initiation and cancer progression (1–7). As such, new therapies for targeting TICs [a.k.a., cancer stem cells (CSCs)] could be used for cancer prevention.bipul r acharya. Cedars Sinai Medical Center. Los Angeles, United States. Associate Editor. Molecular and Cellular Oncology. fedex. tracking Are you an oncology nurse looking to expand your knowledge and advance your career? Look no further than free online oncology nursing CEU courses. Online learning has revolutionize...Added 14 August 2012 • Updated 12 January 2024. A peer-reviewed, open access journal in cancer research, clinical oncology, cancer genetics, molecular targets & surgical oncology.Many modern immunotherapies focus on blood-based cancers, like the leukemias and lymphomas that ONO researcher's study, but solid tumours could also benefit ... spider solitare free penelope jayne duerksen-hughes. Loma Linda University. Loma Linda, United States. Associate Editor. Gynecological Oncology. Part of a multidisciplinary journal, this section explores the development of a personalized and tailored approach to the prevention and treatment of gynecologic malignancies. how to text someone anonymously Frontiers in Oncology. Published by Frontiers. Online ISSN: 2234-943X. Disciplines: Geriatrics and Gerontology. Journal website Author guidelines. Top read articles. 211 reads in the past...The official journal of the International Union of Immunological Societies (IUIS) and the most cited in its field, leading the way for research across basic, translational and clinical immunology. how to watch peacock tv » Frontiers in Oncology. Abbreviation: FRONT ONCOL ISSN: 2234-943X eISSN: 2234-943X Category / Quartile: ONCOLOGY - SCIE(Q2) WoS Core Citation Indexes: SCIE - Science Citation Index Expanded. Impact Factor (IF): 4.7 Journal Citation Indicator (JCI): 0.89 Citations: 43,416 usaf pt calculator The Pediatric Oncology section of Frontiers in Oncology aims to provide fair and rapid peer review in order to publish scientific advances for the benefit of all members of the pediatric oncology community, from basic scientists, to clinical researchers, and to caregivers. Pediatric Oncology has experienced great successes in the last 40 years ... Scope. Breast Cancer is a specialty section of Oncology dedicated to advancing scientific and clinical knowledge of breast cancers. This section seeks to publish articles addressing novel findings, controversies, and innovative hypotheses in the areas of prevention, diagnosis, and treatment of early breast lesions and breast malignancies.